Concurrent Chemoradiotherapy with Low-Dose Cisplatin plus 5-Fluorouracil for the Treatment of Patients with Unresectable Head and Neck Cancer

Publisher： Karger

E-ISSN： 1423-0232|63|3|226-231

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.3, 2002-10, pp. : 226-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 104-113

Karger

Access to resources Recommend Favorite

Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 337-342

Karger

Access to resources Recommend Favorite

Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 10, 2015-10 ,pp. : 1638-1643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1638-1643

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer

By  

Oncology, Vol. 93, Iss. 2, 2017-05 ,pp. : 75-82

Karger

Access to resources Recommend Favorite